Navigation Links
New Drug Combination For Fighting Tuberculosis

The Government of Zimbabwe has applied for a financial grant amounting to approximately 110// million U.S. dollars, to develop a new drug for combating tuberculosis, said the Cabinet Minister. //

The application has been forwarded to the Global Fund on AIDS, TB and Malaria, according to the Health and Child Welfare Minister. It is anticipated that approximately 15 and 30 million dollars would be approved for fighting against tuberculosis, and HIV/AIDS, malaria respectively.

The new drug combination called as Facility Design Criteria reduces the number of drugs taken by a tuberculosis patient per day. Currently, patients with tuberculosis are required to take a total of 14 tablets. This increased drug number however, results in a large number of patients discontinuing the therapy.

The new drug would not be a replacement for the currently existing treatment, called Direct Observed Treatment Strategy (DOTS). However, both the modalities would be followed.

The new form of treatment has already been implemented in countries such as South Africa and Kenya. The risk of contracting tuberculosis (opportunistic infection) is considerably greater among individuals with AIDS/HIV, and is a major cause for mortality in Zimbabwe.

"As soon as we receive funding from the Global Fund, the new range of drug-fixed dose combination will be introduced," concluded the health minister.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... 2017 , ... Collins Concrete Coatings announced that they offer ... safety and cleanliness. This unique flooring system uses silver ion technology to resist ... for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ions attack ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... customer service and innovation, the company recently unveiled a redesigned website. The new ... enrich the work of building owners, architects, contractors and other industry users that ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey Pot Company ... The goal is to ignite conversation via social media and word-of-mouth regarding vaginal ... has declared September “Humans with Vaginas” month, releasing a video celebrating the power ...
(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute (HSI) is offering ... 24- and 40-Hour courses from now until November 30, 2017 to assist with the ... discounted prices to all businesses and government agencies – whether or not they will ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... has been named the official orthopedic and sports medicine ... 2018 College Football Playoff (CFP) National Championship to be played ... Atlanta, Georgia . OrthoAtlanta is proud to be ... many activities leading up to, and including the national championship ... OrthoAtlanta serves ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
Breaking Medicine Technology: